College of Osteopathic Medicine

Search results

• Data on Cancer Reported by Researchers at Oklahoma State University Center for Health Sciences (Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Abiraterone Clinical Trials)

  Vassar, M., Johnson, B. & Hughes, G.

  13/12/24

  1 item of Media coverage

  Press/Media

• Biohaven Pharmaceutical Holding decreases 6.2% in 2024

  Thomas, M.

  13/12/24

  1 item of Media coverage

  Press/Media

• Collegium Pharmaceutical decreases 2.2% in 2024

  Thomas, M.

  13/12/24

  1 item of Media coverage

  Press/Media

• Reports from Oklahoma State University Center for Health Sciences Add New Data to Research in Lung Cancer (Assessing the Uptake of the Lung Cancer Core Outcome Set: A Cross-Sectional Analysis)

  Vassar, M., Ford, A. & Hughes, G.

  11/12/24

  1 item of Media coverage

  Press/Media

• Weekly: Collegium Pharmaceutical (COLL: $29.97) decreases 1.7% on weak volume; -53c [1.7%]

  Thomas, M.

  7/12/24

  1 item of Media coverage

  Press/Media

• Weekly: Biohaven Pharmaceutical Holding (BHVN: $44.80) drops 2.6% on weak volume; -$1.21 [2.6%]

  Thomas, M.

  7/12/24

  1 item of Media coverage

  Press/Media

• OSU/A&M Regents approve personnel actions

  Hanson, C.

  6/12/24

  1 item of Media coverage

  Press/Media

• OSU/A&M REGENTS APPROVE PERSONNEL ACTIONSNEW APPOINTMENTSCHANGES IN APPOINTMENT

  Hanson, C.

  6/12/24

  1 item of Media coverage

  Press/Media

• Winners Announced for 2024 OSU App Competition

  Morris, A.

  5/12/24

  1 item of Media coverage

  Press/Media

• Biohaven Pharmaceutical Holding increases 7.5% in 2024

  Thomas, M.

  3/12/24

  1 item of Media coverage

  Press/Media

• Biohaven Pharmaceutical Holding advances 47% in past year

  Thomas, M.

  3/12/24

  1 item of Media coverage

  Press/Media

• Winners announced for 2024 OSU App Competition

  Morris, A.

  3/12/24

  1 item of Media coverage

  Press/Media

• Collegium Pharmaceutical adds 20% in past year

  Thomas, M.

  3/12/24

  1 item of Media coverage

  Press/Media

• Collegium Pharmaceutical decreases 0.9% in 2024

  Thomas, M.

  3/12/24

  1 item of Media coverage

  Press/Media

• Monthly: Biohaven Pharmaceutical Holding (BHVN: $46.01) shares post worst month in six months

  Thomas, M.

  2/12/24

  1 item of Media coverage

  Press/Media

• WINNERS ANNOUNCED FOR 2024 OSU APP COMPETITION

  Morris, A.

  2/12/24

  1 item of Media coverage

  Press/Media

• WINNERS ANNOUNCED FOR 2024 OSU APP COMPETITION

  Morris, A.

  2/12/24

  1 item of Media coverage

  Press/Media

• Monthly: Collegium Pharmaceutical (COLL: $30.50) wipes off $151 million in MCap in November, highest loser in Medical/Drugs sector

  Thomas, M.

  2/12/24

  1 item of Media coverage

  Press/Media

• Monthly: Biohaven Pharmaceutical Holding (BHVN: $46.01) shares post worst month in six months

  Thomas, M.

  29/11/24

  1 item of Media coverage

  Press/Media

• Weekly: Biohaven Pharmaceutical Holding (BHVN: $45.59) lifts 2.7% on weak volume; +$1.20 [2.7%]

  Thomas, M.

  23/11/24

  1 item of Media coverage

  Press/Media

• Weekly: Collegium Pharmaceutical (COLL: $29.96) increases 1.3% on average volume; +38c [1.3%]

  Thomas, M.

  23/11/24

  1 item of Media coverage

  Press/Media

• Johnson powers Muncy past Delone Catholic in state quarterfinals

  Johnson, A.

  22/11/24 → 23/11/24

  2 items of Media coverage

  Press/Media

• Delone Catholic football's historic season ends vs. Muncy in state quarterfinals

  Johnson, A.

  23/11/24

  1 item of Media coverage

  Press/Media

• These Westchester School Districts Schedule Delayed Starts

  Johnson, A.

  22/11/24

  1 item of Media coverage

  Press/Media

• CHECKETTS NAMED OUTSTANDING RESIDENT OF THE YEAR IN ORTHOPEDICS

  Vassar, M. & Checketts, J.

  20/11/24

  1 item of Media coverage

  Press/Media